Collegium Pharmaceutical
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
9.567.676.115.01
Price/Sales ratio
2.162.242.572.67
Earnings per Share (EPS)
$3.90$4.87$6.11$7.45

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-5.12-13.66-4.01-7.46-14.42-84.4925.769.12-31.3921.56-31.63-84.49
Price/Sales ratio
N/AN/A220.7919.612.012.322.222.351.691.831.702.32
Price/Book Value ratio
-7.504.372.805.366.167.873.703.214.025.314.057.87
Price/Cash Flow ratio
-5.11-17.26-5.03-8.333.3324.787.336.306.313.786.363.33
Price/Free Cash Flow ratio
-5.11-16.98-4.84-8.213.8932.25-2.466.426.403.786.453.89
Price/Earnings Growth ratio
-0.480.84-0.040.200.271.05-0.060.050.23-0.060.231.05
Dividend Yield
N/A6.59%6.50%N/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/A87.55%90.88%40.91%34.72%58.00%54.40%45.15%57.54%45.15%40.91%
Operating Profit Margin
N/AN/A-5498.65%-264.94%-7.37%-8.00%-1.64%-16.86%-22.54%29.45%7.18%-7.37%
Pretax Profit Margin
N/AN/A-5504.14%-262.90%-13.95%-7.65%8.89%-1.21%-6.21%13.36%-6.21%-13.95%
Net Profit Margin
N/AN/A-5504.14%-262.90%-13.95%-2.74%8.62%25.83%-5.38%8.49%-5.38%-13.95%
Effective Tax Rate
-1.40%0.33%-0.09%1.55%283.44%64.14%3.00%2219.65%13.32%36.41%13.32%64.14%
Return on Assets
-352.00%-27.89%-58.12%-55.22%-13.43%-2.66%4.15%10.33%-2.12%4.21%-2.12%-13.43%
Return On Equity
146.36%-32.03%-69.80%-71.93%-42.72%-9.31%14.38%35.24%-12.83%24.64%-12.72%-42.72%
Return on Capital Employed
331.61%-29.26%-67.64%-72.48%-19.93%-21.78%-1.12%-10.11%-11.56%24.35%4.50%-19.93%
Liquidity Ratios
Current Ratio
N/A11.486.194.231.251.261.16N/AN/AN/A0.961.26
Quick Ratio
0.4316.806.854.181.221.241.371.291.381.100.821.24
Cash ratio
0.1516.596.683.760.780.860.910.800.640.520.400.86
Days of Sales Outstanding
N/AN/A454.17127.78101.4589.7498.09139.53144.06115.61144.06101.45
Days of Inventory outstanding
N/AN/A2.25K255.0017.2218.1743.7750.2866.7049.0466.7017.22
Operating Cycle
N/AN/A2.70K382.78118.68107.92141.87189.82210.77164.66102.22107.92
Days of Payables Outstanding
N/A7.54K15.60K799.4826.7611.7728.0812.115.0113.185.0111.77
Cash Conversion Cycle
N/AN/A-12.89K-416.6991.9196.14113.79177.71205.76151.47155.5091.91
Debt Ratios
Debt Ratio
2.550.060.020.010.030.030.400.360.590.580.830.03
Debt Equity Ratio
-1.060.080.030.010.120.131.381.233.603.455.020.12
Long-term Debt to Capitalization
-1.250.040.01N/A0.090.080.520.490.730.710.730.09
Total Debt to Capitalization
16.980.070.020.010.110.120.580.550.780.770.780.11
Interest Coverage Ratio
N/A-61.29-1.00K-129.63-1.02-26.121.94N/AN/AN/A0.52-1.02
Cash Flow to Debt Ratio
-1.37-3.16-18.10-45.3114.722.280.360.410.170.400.172.28
Company Equity Multiplier
-0.411.141.201.303.183.503.463.416.025.856.023.18
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/A-43.86-2.350.600.090.300.370.260.480.260.09
Free Cash Flow / Operating Cash Flow Ratio
1.001.011.031.010.850.76-2.970.980.980.990.980.85
Cash Flow Coverage Ratio
-1.37-3.16-18.10-45.3114.722.280.360.410.170.400.172.28
Short Term Coverage Ratio
-2.89-8.08-28.14-45.31103.166.181.942.100.751.490.756.18
Dividend Payout Ratio
N/A-90.15%-26.09%N/AN/AN/AN/AN/AN/AN/AN/AN/A